Andrea Diblasio Frake
Nurse Practitioner · New York, NYNPI 1689749962
Payments from drug & device makers
Across 60 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$387
- AbbVie$139
- Astellas Pharma US Inc$109
- Sage Therapeutics, LLC$65
- Sumitomo Pharma America, Inc.$55
- Organon$43
- plus $253 from 10 others
What the payments were for
- Food & beverage$1,01396%
- Education$404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 21 | $387 |
| AbbVie | 9 | $139 |
| Astellas Pharma US Inc | 6 | $109 |
| Sage Therapeutics, LLC | 4 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Organon | 3 | $43 |
| Exeltis, USA Inc. | 3 | $40 |
| Millicent US Inc | 1 | $40 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| Bayer | 1 | $25 |
| Boston Scientific | 1 | $22 |
| Therapeuticsmd, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIJUVA$104
How this compares
$1,053 in reported general payments places this provider in the 85th percentile of 4,112 nurse practitioner providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 95 | $6,188 |
| ValacyclovirValacyclovir Hcl | 16 | $563 |
| Ibandronate Sodium | 12 | $385 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 23 | $244 |
| Clobetasol Propionate | 17 | $189 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $152 |
| Fluconazole | 22 | $100 |
| Nystatin | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in New York
- Patricia McGoldrickNew York$202K
- Jodi LogerfoNew York$48K
- Aileen FerrickNew York$26K
- Tsz Isabel WongNew York$25K
- Chris BustamanteNew York$22K
- Mayra PozoNew York$14K
- Janet JohnsonNew York$12K
- Rachel RankinNew York$10K
- Richelle CassellNew York$10K
- Michelle DartSyracuse$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.